Dolsten Mikael — SEC Form 4 filings
SEC reporting owner CIK 1437590. 16 Form 4 filings on record with FilingPulse; latest filed 2026-09-09.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2024-02-27 to 2026-09-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 3 filings — 4,834 shares, $702,155 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
- Largest priced transaction: sale of 2,600 shares @ $149.81 ($389,511) in AGILENT TECHNOLOGIES, INC., filed 2025-12-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| AGILENT TECHNOLOGIES, INC. (A) | Director | 6 | — | 3 legs · 4,834 sh · $702,155 | 3 |
| PFIZER INC (PFE) | President R&D | 4 | — | — | 8 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | Director | 4 | — | — | 6 |
| Apellis Pharmaceuticals, Inc. (APLS) | Director | 2 | — | — | 5 |
Form 4 filings — Dolsten Mikael
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-09 | 4 | AGILENT TECHNOLOGIES, INC. (A) | Sale (S): 634 @ $151.38 | EDGAR |
| 2026-07-06 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Grant/award (A): 22,862 @ $0 · Grant/award (A): 64,860 (derivative) @ $0 | EDGAR |
| 2026-06-02 | 4 | AGILENT TECHNOLOGIES, INC. (A) | Sale (S): 1,600 @ $135.42 | EDGAR |
| 2026-05-14 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Code (U): 14,312 · Disposition to issuer (D): 14,312 · Disposition to issuer (D): 24,135 (derivative) | EDGAR |
| 2026-03-23 | 4 | AGILENT TECHNOLOGIES, INC. (A) | Grant/award (A): 2,158 @ $111.75 | EDGAR |
| 2026-03-03 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Grant/award (A): 14,312 @ $0 · Grant/award (A): 24,135 (derivative) @ $20.96 | EDGAR |
| 2025-12-03 | 4 | AGILENT TECHNOLOGIES, INC. (A) | Sale (S): 2,600 @ $149.81 | EDGAR |
| 2025-07-18 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Grant/award (A): 30,000 @ $0 | EDGAR |
| 2025-04-24 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Other (J): 14,220 @ $0 | EDGAR |
| 2025-03-18 | 4 | AGILENT TECHNOLOGIES, INC. (A) | Grant/award (A): 1,819 @ $121.18 | EDGAR |
| 2024-09-16 | 4 | PFIZER INC (PFE) | Disposition to issuer (D): 137,760 (derivative) @ $0 · Grant/award (A): 137,760 (derivative) @ $0 · Disposition to issuer (D): 126,794 (derivative) @ $0 · Grant/award (A): 126,794 (derivative) @ $0 | EDGAR |
| 2024-09-11 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Grant/award (A): 27,545 (derivative) @ $0 · Grant/award (A): 22,988 (derivative) @ $0 | EDGAR |
| 2024-03-19 | 4 | AGILENT TECHNOLOGIES, INC. (A) | Grant/award (A): 1,678 @ $147.48 | EDGAR |
| 2024-02-29 | 4 | PFIZER INC (PFE) | Tax withholding (F): 21,437 @ $27.04 | EDGAR |
| 2024-02-28 | 4 | PFIZER INC (PFE) | Grant/award (A): 214,880 (derivative) @ $0 · Grant/award (A): 189,867 (derivative) @ $0 | EDGAR |
| 2024-02-27 | 4 | PFIZER INC (PFE) | Tax withholding (F): 24,822 @ $27.76 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1437590 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →